Auswahl der wissenschaftlichen Literatur zum Thema „Pregnancy continuation“

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Pregnancy continuation" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Pregnancy continuation"

1

Ayerbe, Luis, María Pérez-Piñar, Cristina López del Burgo und Eduardo Burgueño. „Continuation of Unintended Pregnancy“. Linacre Quarterly 86, Nr. 2-3 (24.03.2019): 161–67. http://dx.doi.org/10.1177/0024363919838368.

Der volle Inhalt der Quelle
Annotation:
Background: Forty-four percent of all pregnancies worldwide are unintended. Induced abortion has drawn a lot of attention from clinicians and policy makers, and the care for women requesting it has been covered in many publications. However, abortion challenges the values of many women, is associated with negative emotions, and has its own medical complications. Women have the right to discuss their unintended pregnancy with a clinician and receive elaborate information about other options to deal with it. Continuing an unintended pregnancy, and receiving the necessary care and support for it, is also a reproductive right of women. However, the provision of medical information and support required for the continuation of an unintended pregnancy has hardly been approached in the medical literature. Objective: This review presents a clinical approach to unintentionally pregnant patients and describes the information and support that can be offered for the continuation of the unintended pregnancy. Discussion: Clinicians should approach patients with an unintended pregnancy with a sympathetic tone in order to provide the most support and present the most complete options. A complete clinical history can help frame the problem and identify concerns related to the pregnancy. Any underlying medical or obstetric problems can be discussed. A social history, that includes the personal support from the patient’s partner, parents, and siblings, can be taken. Doctors should also be alert of possible cases of violence from the partner or child abuse in adolescent patients. Finally, the clinician can provide the first information regarding the social care available and refer the patients for further support. For women who continue an unintended pregnancy, clinicians should start antenatal care immediately. Conclusion: Unintentionally pregnant women deserve a supportive and complete response from their clinicians, who should inform about, and sometimes activate, all the resources available for the continuation of unintended pregnancy. Summary Forty-four percent of all pregnancies worldwide are unintended. Induced abortion has drawn a lot of attention and the care for women requesting it has been covered in many publications. However, abortion challenges the values of many women, is associated with negative emotions, and has its own medical complications. Women have the right to discuss their unintended pregnancy with a clinician and receive elaborate information about other options to deal with it. Continuing an unintended pregnancy, and receiving the necessary care and support for it, is also a reproductive right of women. However, the provision of medical information and support required for the continuation of an unintended pregnancy has hardly been approached in the medical literature. This review presents a clinical approach to unintentionally pregnant patients and describes the information and support that can be offered for the continuation of the unintended pregnancy. Clinicians should approach patients with an unintended pregnancy with a sympathetic tone. A complete clinical history can help frame the problem and identify concerns related to the pregnancy. Any underlying medical or obstetric problems can be discussed. A social history, that includes the personal support from the patient's partner, parents, and siblings, can be taken. Doctors should also be alert of possible cases of violence from the partner or child abuse in adolescent patients. Finally, the clinician can provide the first information regarding the social care available and refer the patients for further support. For women who continue an unintended pregnancy, clinicians should start antenatal care immediately.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

KIRN, TIMOTHY F. „Consider Hydroxychloroquine Continuation in Lupus Pregnancy“. Family Practice News 36, Nr. 7 (April 2006): 37. http://dx.doi.org/10.1016/s0300-7073(06)72951-6.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Birnholz, Jason C., W. Paul Dmowski, Zvi Binor und Ewa Radwanska. „Selective continuation in gonadotropin-induced multiple pregnancy“. Fertility and Sterility 48, Nr. 5 (November 1987): 873–76. http://dx.doi.org/10.1016/s0015-0282(16)59547-8.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Deiana, Valeria, Caterina Chillotti, Mirko Manchia, Paolo Carta, Alberto Bocchetta, Raffaella Ardau und Maria Del Zompo. „Continuation Versus Discontinuation of Lithium During Pregnancy“. Journal of Clinical Psychopharmacology 34, Nr. 3 (Juni 2014): 407–10. http://dx.doi.org/10.1097/jcp.0000000000000059.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Birnholz, JC, WP Dmowski, Z. Binor und E. Radwanska. „Selective continuation in gonadotropin-induced multiple pregnancy“. International Journal of Gynecology & Obstetrics 27, Nr. 2 (Oktober 1988): 311–12. http://dx.doi.org/10.1016/0020-7292(88)90043-4.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Wen, Timothy, Eve Overton, Yongmei Huang, Jason D. Wright, Mary E. D'Alton und Alexander M. Friedman. „684: Continuation of psychiatric medications during pregnancy“. American Journal of Obstetrics and Gynecology 222, Nr. 1 (Januar 2020): S433. http://dx.doi.org/10.1016/j.ajog.2019.11.698.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Kharkova, O. A., A. G. Soloviev, L. G. Kiseleva, G. N. Chumakova und E. M. Gryzunova. „PREDICTIVE MODEL OF TOBACCO SMOKING CONTINUATION DURING PREGNANCY“. Human Ecology, Nr. 7 (14.07.2017): 53–55. http://dx.doi.org/10.33396/1728-0869-2017-7-53-55.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Deliveliotis, Ch, B. Argyropoulos, M. Chrisofos und C. A. Dimopoulos. „Shockwave Lithotripsy in Unrecognized Pregnancy: Interruption or Continuation?“ Journal of Endourology 15, Nr. 8 (Oktober 2001): 787–88. http://dx.doi.org/10.1089/089277901753205744.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Lakasing, Lorin, und John A. D. Spencer. „Continuation of pregnancy after mid-trimester gemeprost administration“. BJOG: An International Journal of Obstetrics and Gynaecology 106, Nr. 12 (Dezember 1999): 1319–20. http://dx.doi.org/10.1111/j.1471-0528.1999.tb08191.x.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Sentilhes, Loïc, Fabrice Sergent und Loïc Marpeau. „Repair of Uterine Dehiscence With Continuation of Pregnancy“. Obstetrics & Gynecology 105, Nr. 6 (Juni 2005): 1487–88. http://dx.doi.org/10.1097/01.aog.0000167707.91658.82.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Dissertationen zum Thema "Pregnancy continuation"

1

Elfarawi, Hunaydah. „Alobar Holoprosencephaly: Parental Perspectives on Prenatal Decision-making, Prenatal Provider Prognostication, and Quality of Life“. University of Cincinnati / OhioLINK, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1617108856885634.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Bücher zum Thema "Pregnancy continuation"

1

Mathiesen, Amber, und Kali Roy. Pregnancy Management. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190681098.003.0007.

Der volle Inhalt der Quelle
Annotation:
This chapter describes a patient’s pregnancy options and subsequent care after a pregnancy becomes “high risk” due to a known genetic condition or birth defect. It reviews the reproductive options available, including continuation of pregnancy, adoption, and pregnancy termination. The timing of pregnancy termination is described, including methods used during the first and second trimesters, as well as later term. This chapter also reviews the possible management referrals that may be made if the patient chooses to continue the pregnancy, including perinatology, specialized imaging, cardiology, neonatology, fetal surgery and interventions, pediatric surgery, pediatric subspecialties, pathology, and palliative care. It also discusses referrals for further support.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Allegaert, Karel, und Kristel Van Calsteren. Maternal, fetal, and neonatal pharmacokinetics. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198713333.003.0005.

Der volle Inhalt der Quelle
Annotation:
Most drugs are not thoroughly evaluated for use during pregnancy, delivery, or postpartum (e.g. breastfeeding). The same holds true for early infancy, and results in extensive off-label, unlicensed pharmacotherapy in these specific subpopulations. At present, most drug labels do not contain any instructions for use during pregnancy, in infancy, or during breastfeeding, yet these are the main concerns of healthcare providers considering medical treatment. Anaesthetists commonly treat pregnant women with similar dosing regimens recommended for use in adults and subsequently titrate to effect. The (dis)continuation of breastfeeding in the postpartum period following anaesthesia is commonly based on opinions instead of scientific evidence. This chapter describes the alterations in pharmacokinetics (absorption, distribution, metabolism, elimination) in pregnant women with specific emphasis on placental drug transport, and in neonates, with additional emphasis on breastfeeding. Drugs commonly administered by anaesthetists to women in the peripartum period are discussed with particular reference to the changed pharmacodynamics in both mother and infant.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

McKinlay Gardner, R. J., und David J. Amor. Chromosome Abnormalities Detected at Prenatal Diagnosis. Herausgegeben von R. J. McKinlay Gardner und David J. Amor. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199329007.003.0021.

Der volle Inhalt der Quelle
Annotation:
Prenatal diagnosis has given medical cytogenetics one of its major areas of application: from amniocentesis in the earliest days to the recent developments of noninvasive prenatal testing based upon a sample of maternal blood. This chapter explores in detail the specific diagnoses that may be made and the decisions, with particular reference to continuation or termination of pregnancy, that face those women/couples for whom a specific diagnosis has been made. The difficulties of decision inherent in a sex chromosome aneuploidy, a microarray-level rearrangement, and in the context of mosaicism are rehearsed. This discussion is offered on the background of a review of the applied embryology.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Hopper, John A., und Theodore V. Parran. Revising the Treatment Plan and/or Ending Addiction Treatment (DRAFT). Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190265366.003.0023.

Der volle Inhalt der Quelle
Annotation:
Where Chapter 18 discusses revision of the treatment plan and ending of pain treatment, Chapter 23 focuses on the conclusion of addiction treatment. It closes the loop to Chapter 11, Initiating Treatment and Monitoring Patient Progress. The authors describe the conditions which will oblige a revision of the treatment plan; such as alterations in prescription medications with cross-metabolism, pregnancy or menopause, liver disease, or aging. There are also behavioral conditions that will oblige plan modification, whether dysfunctional or hostile behaviors or other psychiatric instability. Consequently, a significant portion of the chapter is dedicated to the identification of relapse, its psychodynamic and developmental meanings, and the appropriate interventions for it. Voluntary and involuntary terminations and the therapeutic steps taken with both are discussed as logical continuations of any treatment plan.
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Buchteile zum Thema "Pregnancy continuation"

1

Cole, Laurence A. „Pregnancy-3, creation and continuation of hemochorial placentation“. In Human Chorionic Gonadotropin (HGC), 133–39. Elsevier, 2015. http://dx.doi.org/10.1016/b978-0-12-800749-5.00014-6.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Grentzer, Jaclyn. „Long-Acting Reversible Contraception (LARC) and Teen Pregnancy“. In 50 Studies Every Obstetrician-Gynecologist Should Know, 159–63. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780190947088.003.0029.

Der volle Inhalt der Quelle
Annotation:
Long-acting, reversible contraception (LARC), including intrauterine devices (IUDs) and contraceptive implants, are associated with higher contraceptive efficacy and continuation rates. Teen pregnancy rates have declined over the past 2 decades but continue to be a public health concern. Only 10% of teen girls elect to use LARC, likely due to educational, logistical, and economic barriers. The Contraceptive CHOICE Project enrolled 1404 girls aged 14 to 19. Of these teens, more than 70% chose LARC when given standardized contraceptive counseling and barriers to receiving LARC were removed. Pregnancy, live birth, and induced abortion rates in this cohort were lower than rates for the US population of sexually active teen girls. Failure rates were lower for LARC users, as compared to users of other reversible contraceptive methods.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Jones, Ian, und Arianna Di Florio. „Perinatal psychiatry“. In New Oxford Textbook of Psychiatry, herausgegeben von John R. Geddes, Nancy C. Andreasen und Guy M. Goodwin, 767–76. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198713005.003.0073.

Der volle Inhalt der Quelle
Annotation:
Perinatal psychiatric disorders are common, with around 10% of women experiencing depressive symptoms in pregnancy or in the months after delivery. They may also be severe, with post-partum psychosis representing some of the most severe episodes of illness seen in psychiatric practice. Perinatal mental illness is not only significant for the health of the mother, but also for the well-being of her child, and may have a considerable impact on her family and wider society. Despite their importance, maternal psychiatric disorders remain underdiagnosed and undertreated. This chapter will focus attention on episodes of severe mental illness occurring in the periantal period but will also consider other, more common mental disorders. The chapter will consider both episodes having their onset in the perinatal period and those that represent a continuation of pre-existing condition.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Dennis, Cindy-Lee, und Therese Dowswell. „Psychosocial and psychological interventions for the prevention of postpartum depression: An updated systematic review“. In Perinatal Psychiatry. Oxford University Press, 2014. http://dx.doi.org/10.1093/oso/9780199676859.003.0008.

Der volle Inhalt der Quelle
Annotation:
The author gratefully acknowledges Dr Debra Creedy who assisted Dr Dennis with the first version of this review in 2004. The author also wishes to thank: Julie Weston for her data extraction, independent evaluation of trial quality, contacting trial authors as necessary, and data entry; Danni Li for translating Sun 2004; Tang 2009; and Xu 2003. Edward Plaisance Jr for translating Ajh 2006. Alison Balmfirth, Laura Wills, Ed Doragh, and Nivene Raafat for translating Bittner 2009. Aoife Fogarty for translating Kleeb 2005. Francesca Gatenby, Nick Jones, and Juliet Sheath for translating Urech 2009; and the many study authors who were very helpful in responding to queries and providing additional data. Depression is a major cause of disability for all ages and both sexes worldwide. Postpartum depression is often defined as depression occurring within the first year following childbirth. In most studies this includes those women for whom the depression may be a continuation of that experienced during pregnancy, as well as those for whom it is a new onset. The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) does not recognize postpartum depression as diagnostically distinct from depression at other times, although does allow for the addition of a ‘postpartum-onset specifier’ in women with an onset within 4 weeks of birth. A recent systematic review of postpartum depression found the period prevalence of all depression to be 19.2% in the first 12 weeks postnatally, with a period prevalence for major depression of 7.1% (Gaynes et al. 2005). This review also identified depression to be common during pregnancy with a period prevalence of 18.4% across the 9 months of pregnancy, with 12.7% having an episode of major depression during this time. Not surprisingly, antenatal depression is a strong risk factor of postpartum depression. The cause of postpartum depression suggests a multifactorial aetiology (Beck 2001; O’Hara and Swain 1996). Despite considerable research, no single causative factor has been isolated. However, meta-analytic findings consistently highlight the importance of psychosocial variables such as stressful life events, marital conflict, and the lack of social support.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Fink MD, Max. „What Is Electroconvulsive Therapy?“ In Electroconvulsive Therapy. Oxford University Press, 2010. http://dx.doi.org/10.1093/oso/9780195365740.003.0005.

Der volle Inhalt der Quelle
Annotation:
Electroconvulsive therapy (ECT) is an effective medical treatment for severe and persistent psychiatric disorders. It relieves de pressed mood and thoughts of suicide, as well as mania, acute psychosis, delirium, and stupor. It is usually applied when medications have given limited relief or their side effects are intolerable. Electroconvulsive therapy is similar to a surgical treatment. It requires the specialized skills of a psychiatrist, an anesthesiologist, and nurses. The patient receives a short-acting anesthetic. While the patient is asleep, the physician, following a prescribed procedure, induces an epileptic seizure in the brain. By making sure that the patient’s lungs are filled with oxygen, the physician precludes the gasping and difficult breathing that accompany a spontaneous epileptic fit. By relaxing the patient’s muscles with chemicals and by inserting a mouth guard (not unlike those used in sports), the physician prevents the tongue biting, fractures, and injuries that occasionally occur in epilepsy. The patient is asleep, and so experiences neither the painful effects of the stimulus nor the discomforts of the seizure. The physiological functions of the body, such as breathing, heart rate, blood pressure, blood oxygen concentration, and degree of motor relaxation, are monitored, and anything out of the ordinary is immediately treated. Electroconvulsive therapy relieves symptoms more quickly than do psychotropic drugs. A common course of ECT consists of two or three treatments a week for two to seven weeks. To sustain the recovery, weekly or biweekly continuation treatments, either ECT or medications, are often administered for four to six months. If the illness recurs, ECT is prescribed for longer periods. The duration and course of ECT are similar to those of the psychotropic medicines frequently used for the same conditions. Electroconvulsive therapy has been used safely to treat emotional disorders in patients of all ages, from children to the elderly, in people with debilitating physical illnesses, and in pregnant women. Emotional disorders may be of short or long duration; they may be manifest as a single episode or as a recurring event. Electroconvulsive treatment is an option when the emotional disorder is acute in onset; when changes in mood, thought, and motor activities are pronounced; when the cause is believed to be biochemical or physiological; when the condition is so severe that it interferes with the patient’s daily life; or when other treatments have failed.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie